Mission Statement, Vision, & Core Values (2026) of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong.

Founded in 1964 in Zhaoqing, Guangdong, Star Lake Bioscience Co., Inc. has grown into a biotechnology powerhouse with over 5,000 employees, a diversified portfolio of APIs and natural products, and a sustained compound annual growth rate of roughly 20%, underpinned by a focused mission to advance bioscience through innovation, stringent quality control and sustainable practices; the company channels about $10 million annually into R&D, sources some 75% of its raw materials from renewable suppliers, reported a 30% reduction in greenhouse gas emissions by 2023 and achieved a 98.5% customer satisfaction rating in 2023, all of which position Star Lake to pursue its vision of global leadership in pharmaceutical and agricultural biotechnology while maintaining environmental responsibility and excellence in product quality

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) - Intro

• Founded: 1964
• Headquarters: Zhaoqing, Guangdong, China
• Employees: ~5,200
• Core businesses: APIs, natural products, biochemicals for pharma and health industries
• Historical growth: compound annual growth rate (CAGR) ≈ 20% (company-declared long-term average)

• To develop and supply high-quality, safe and effective biological ingredients that enable better healthcare and wellness worldwide.
• To maintain rigorous quality systems and regulatory compliance across all production and R&D activities.

• To be the trusted global supplier of advanced biological APIs and natural products, advancing therapeutic options and sustainable biologics manufacturing.
• To lead in scalable, environmentally responsible biotech production that meets global pharmaceutical standards.

• Quality First - uncompromising adherence to GMP, GLP and ISO standards.
• Innovation - sustained R&D investment to expand technical capabilities and product pipelines.
• Sustainability - minimizing environmental footprint through green chemistry and waste reduction.
• Integrity - transparent governance, compliance with global regulatory frameworks and ethical sourcing.
• Customer Focus - partnering with pharma, nutraceutical and cosmetic customers to deliver tailored solutions.

• Scale-up of high-margin APIs and proprietary natural extracts to capture global pharma demand.
• Continued R&D allocation (~8% of revenue) to support new product registration and process optimization.
• Investment in manufacturing capacity and automation to improve yields and reduce per-unit costs.
• Expansion of international channels to sustain export share (currently ~60%) and diversify market risk.

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) - Overview

• Mission: Drive bioscience advancement through cutting-edge R&D, rigorous quality control and sustainable operations.
• Vision: Be a leading, trusted supplier of bioscience products that improve global health outcomes while minimizing environmental impact.
• Core values: Scientific excellence, product quality, environmental stewardship, customer-centricity and compliance with international standards.

• Annual R&D investment: approximately $10 million directed to new product development, process optimization and translational research partnerships.
• Sustainable sourcing target: 75% of raw materials sourced from renewable or certified sustainable suppliers.
• Quality assurance: adherence to ISO and GMP frameworks across production lines; routine batch release testing and external audits.

• Dedicated R&D centers and pilot manufacturing capacity to shorten commercialization cycles.
• Supplier engagement programs to convert supply base toward certified renewable inputs and traceability.
• Investment in process analytical technology and automation to ensure consistent quality and reduce waste.
• Partnerships with academic and industrial collaborators to co-develop novel assays and biologics.

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) - Mission Statement

• Deliver safe, effective pharmaceutical intermediates and biologically based crop solutions.
• Invest in continuous R&D to accelerate product pipeline and market readiness.
• Operate with transparency, regulatory compliance, and stakeholder accountability.
• Embed sustainability into operations to minimize environmental impact.

• Market leadership in selected pharmaceutical intermediates and biological agrochemicals across Asia and export markets.
• Continuous innovation through a robust R&D pipeline and strategic partnerships with universities and contract research organizations.
• Operational excellence with scalable manufacturing that meets international quality standards (GMP, ISO).
• Environmental responsibility, targeting measurable reductions in greenhouse gas emissions and resource consumption.

• Scientific integrity: rigorous methodology and data transparency in R&D and quality control.
• Customer focus: product reliability and regulatory compliance to meet downstream needs.
• Innovation: sustained investment in novel platforms and process optimization.
• Sustainability: measurable targets for emissions, energy efficiency, and waste reduction.
• Collaboration: strategic alliances across academia, industry, and supply chain partners.

• Scale manufacturing capacity to support 20-30% annual volume growth for key products.
• Allocate ~8% of annual revenue to R&D to advance biologics and agri‑bio pipelines.
• Reduce scope 1 and 2 emissions by an additional 15% by 2025 through energy efficiency and renewables.
• Expand export network to raise international sales share above 50% over the medium term.

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) Vision Statement

• Commitment to Quality: rigorous quality-control systems cover manufacturing, distribution, and after-sales support - reflected in a 98.5% customer satisfaction rating in 2023.
• Innovation-Driven Growth: sustained investment in R&D to accelerate pipeline development and product lifecycle improvements.
• Sustainability & Environmental Responsibility: integrated eco-friendly operations and sourcing, achieving a 30% reduction in greenhouse gas emissions by 2023 vs. baseline year.
• Customer Focus & Market Responsiveness: rapid product adaptation and service-level enhancements to meet evolving clinical and research needs.
• Culture of Excellence: continuous talent development and process optimization to raise product quality and organizational performance.

• R&D acceleration: target R&D spend of ~9.5% of revenue by 2026 to support pipeline diversification and platform technologies.
• Quality assurance: maintain customer satisfaction ≥98% and reduce product non-conformance rates by 25% from 2023 levels over three years.
• Carbon & resource goals: achieve a 50% reduction in greenhouse gas emissions by 2030 (base = 2020) and implement 75% sustainable sourcing for key raw materials by 2028.
• Commercial growth: target compound annual revenue growth of 10-12% through expanded diagnostics, reagent, and biologics support services.